Firm behind Gambia child deaths a repeat offender in India
Friday, 7 October 2022 The Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold locally in India, but the same company, Maiden Pharmaceuticals, has been a repeat offender when it comes to producing substandard medicines in this country, with the earliest instance going back to 2011 when it was blacklisted in Bihar.
Today, Union health minister Mansukh Mandaviya said the Central Drugs Standard Control Organisation (CDSCO) has been in touch with Uzbekistan's national drugs regulator since December 27. This comes as India’s central government's first statement on the deaths of children in Uzbekistan after being given Doc-1 Max, a cough syrup made by Marion Biotech, an Indian manufacturer.
#Uzbekistan #Indiancoughdrop #Doc1Max
India’s January rainfall has hit a five-year low at 12.4 mm, with the month currently running a rainfall deficit of 25%, and the shortfall unlikely to be.. IndiaTimes
Decadal Change of Night Time Light over India from Space (2012-2021), released by Isro’s National Remote Sensing Centre — shows that overall at the national.. IndiaTimes
BJP workers from across Bihar have been categorically told that there was no question of a realignment with "unpopular" chief minister Nitish Kumar, the party's.. IndiaTimes